| Year |
Citation |
Score |
| 2012 |
Nübling G, Levin J, Bader B, Israel L, Bötzel K, Lorenzl S, Giese A. Limited cleavage of tau with matrix-metalloproteinase MMP-9, but not MMP-3, enhances tau oligomer formation. Experimental Neurology. 237: 470-6. PMID 22890115 DOI: 10.1016/j.expneurol.2012.07.018 |
0.517 |
|
| 2009 |
Levin J, Giese A, Boetzel K, Israel L, Högen T, Nübling G, Kretzschmar H, Lorenzl S. Increased alpha-synuclein aggregation following limited cleavage by certain matrix metalloproteinases. Experimental Neurology. 215: 201-8. PMID 19022250 DOI: 10.1016/j.expneurol.2008.10.010 |
0.399 |
|
| 2008 |
Lorenzl S, Buerger K, Hampel H, Beal MF. Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia. International Psychogeriatrics / Ipa. 20: 67-76. PMID 17697439 DOI: 10.1017/S1041610207005790 |
0.68 |
|
| 2007 |
Glas M, Popp B, Angele B, Koedel U, Chahli C, Schmalix WA, Anneser JM, Pfister HW, Lorenzl S. A role for the urokinase-type plasminogen activator system in amyotrophic lateral sclerosis. Experimental Neurology. 207: 350-6. PMID 17716658 DOI: 10.1016/j.expneurol.2007.07.007 |
0.46 |
|
| 2007 |
Kiaei M, Kipiani K, Calingasan NY, Wille E, Chen J, Heissig B, Rafii S, Lorenzl S, Beal MF. Matrix metalloproteinase-9 regulates TNF-alpha and FasL expression in neuronal, glial cells and its absence extends life in a transgenic mouse model of amyotrophic lateral sclerosis. Experimental Neurology. 205: 74-81. PMID 17362932 DOI: 10.1016/J.Expneurol.2007.01.036 |
0.77 |
|
| 2007 |
Kim YS, Choi DH, Block ML, Lorenzl S, Yang L, Kim YJ, Sugama S, Cho BP, Hwang O, Browne SE, Kim SY, Hong JS, Beal MF, Joh TH. A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 21: 179-87. PMID 17116747 DOI: 10.1096/Fj.06-5865Com |
0.745 |
|
| 2006 |
Lorenzl S, Narr S, Angele B, Krell HW, Gregorio J, Kiaei M, Pfister HW, Beal MF. The matrix metalloproteinases inhibitor Ro 28-2653 [correction of Ro 26-2853] extends survival in transgenic ALS mice. Experimental Neurology. 200: 166-71. PMID 16516196 DOI: 10.1016/J.Expneurol.2006.01.026 |
0.725 |
|
| 2004 |
Lorenzl S, Calingasan N, Yang L, Albers DS, Shugama S, Gregorio J, Krell HW, Chirichigno J, Joh T, Beal MF. Matrix metalloproteinase-9 is elevated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice. Neuromolecular Medicine. 5: 119-32. PMID 15075439 DOI: 10.1385/Nmm:5:2:119 |
0.79 |
|
| 2004 |
Lorenzl S, Albers DS, Chirichigno JW, Augood SJ, Beal MF. Elevated levels of matrix metalloproteinases-9 and -1 and of tissue inhibitors of MMPs, TIMP-1 and TIMP-2 in postmortem brain tissue of progressive supranuclear palsy. Journal of the Neurological Sciences. 218: 39-45. PMID 14759631 DOI: 10.1016/J.Jns.2003.10.015 |
0.676 |
|
| 2003 |
Yang L, Sugama S, Chirichigno JW, Gregorio J, Lorenzl S, Shin DH, Browne SE, Shimizu Y, Joh TH, Beal MF, Albers DS. Minocycline enhances MPTP toxicity to dopaminergic neurons. Journal of Neuroscience Research. 74: 278-85. PMID 14515357 DOI: 10.1002/Jnr.10709 |
0.685 |
|
| 2003 |
Lorenzl S, De Pasquale G, Segal AZ, Beal MF. Dysregulation of the levels of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the early phase of cerebral ischemia. Stroke; a Journal of Cerebral Circulation. 34: e37-8; author reply . PMID 12750528 DOI: 10.1161/01.Str.0000075563.45920.24 |
0.685 |
|
| 2003 |
Lorenzl S, Albers DS, Relkin N, Ngyuen T, Hilgenberg SL, Chirichigno J, Cudkowicz ME, Beal MF. Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease. Neurochemistry International. 43: 191-6. PMID 12689599 DOI: 10.1016/S0197-0186(03)00004-4 |
0.71 |
|
| 2003 |
Lorenzl S, Albers DS, LeWitt PA, Chirichigno JW, Hilgenberg SL, Cudkowicz ME, Beal MF. Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases. Journal of the Neurological Sciences. 207: 71-6. PMID 12614934 DOI: 10.1016/S0022-510X(02)00398-2 |
0.671 |
|
| 2003 |
Sugama S, Yang L, Cho BP, DeGiorgio LA, Lorenzl S, Albers DS, Beal MF, Volpe BT, Joh TH. Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL/6 mice. Brain Research. 964: 288-94. PMID 12576189 DOI: 10.1016/S0006-8993(02)04085-4 |
0.617 |
|
| 2002 |
Lorenzl S, Albers DS, Narr S, Chirichigno J, Beal MF. Expression of MMP-2, MMP-9, and MMP-1 and their endogenous counterregulators TIMP-1 and TIMP-2 in postmortem brain tissue of Parkinson's disease. Experimental Neurology. 178: 13-20. PMID 12460604 DOI: 10.1006/Exnr.2002.8019 |
0.728 |
|
| 1998 |
Paul R, Lorenzl S, Koedel U, Sporer B, Vogel U, Frosch M, Pfister HW. Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Annals of Neurology. 44: 592-600. PMID 9778257 DOI: 10.1002/ana.410440404 |
0.468 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2010 |
Levin J, Bötzel K, Giese A, Vogeser M, Lorenzl S. Elevated levels of methylmalonate and homocysteine in Parkinson's disease, progressive supranuclear palsy and amyotrophic lateral sclerosis. Dementia and Geriatric Cognitive Disorders. 29: 553-9. PMID 20606437 DOI: 10.1159/000314841 |
0.243 |
|
| 2010 |
Lorenzl S. Stem cells and the modeling of the extracellular matrix--the library of cells needs suitable bookshelves. Journal of Molecular Medicine (Berlin, Germany). 88: 531-3. PMID 20232193 DOI: 10.1007/s00109-010-0612-7 |
0.239 |
|
| 2020 |
Woitalla D, Krüger R, Lorenzl S, Müller T, Oelwein G, Storch A, Wolz M, Wüllner U. [The role of inhibitors of COMT and MAO-B in the therapy of Parkinson's disease]. Fortschritte Der Neurologie-Psychiatrie. PMID 32588409 DOI: 10.1055/A-1149-9308 |
0.217 |
|
| 2012 |
Gold M, Lorenzl S, Stewart AJ, Morimoto BH, Williams DR, Gozes I. Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy. Neuropsychiatric Disease and Treatment. 8: 85-93. PMID 22347799 DOI: 10.2147/NDT.S12518 |
0.182 |
|
| 2018 |
Eggers C, Dano R, Schill J, Fink GR, Timmermann L, Voltz R, Golla H, Lorenzl S. Access to End-of Life Parkinson's Disease Patients Through Patient-Centered Integrated Healthcare. Frontiers in Neurology. 9: 627. PMID 30105000 DOI: 10.3389/Fneur.2018.00627 |
0.177 |
|
| 2024 |
Kruse C, Lipinski A, Verheyen M, Balzer-Geldsetzer M, Wittenberg M, Lorenzl S, Richinger C, Schmotz C, Tönges L, Woitalla D, Klebe S, Bloem BR, Hommel A, Meissner WG, Laurens B, et al. Care of Late-Stage Parkinsonism: Resource Utilization of the Disease in Five European Countries. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 38425158 DOI: 10.1002/mds.29718 |
0.172 |
|
| 2013 |
Nagel G, Ünal H, Rosenbohm A, Ludolph AC, Rothenbacher D, Arnold G, Adam T, Neusch C, Bäzner H, Börtlein A, Baier H, Behne F, Raape J, Rothmeier J, Beattie J, ... ... Lorenzl S, et al. Implementation of a population-based epidemiological rare disease registry: Study protocol of the amyotrophic lateral sclerosis (ALS) - registry Swabia Bmc Neurology. 13. PMID 23414001 DOI: 10.1186/1471-2377-13-22 |
0.171 |
|
| 2013 |
Zech M, Nübling G, Castrop F, Jochim A, Schulte EC, Mollenhauer B, Lichtner P, Peters A, Gieger C, Marquardt T, Vanier MT, Latour P, Klünemann H, Trenkwalder C, Diehl-Schmid J, ... ... Lorenzl S, et al. Niemann-Pick C disease gene mutations and age-related neurodegenerative disorders. Plos One. 8: e82879. PMID 24386122 DOI: 10.1371/journal.pone.0082879 |
0.167 |
|
| 2011 |
Reichel CA, Uhl B, Lerchenberger M, Puhr-Westerheide D, Rehberg M, Liebl J, Khandoga A, Schmalix W, Zahler S, Deindl E, Lorenzl S, Declerck PJ, Kanse S, Krombach F. Urokinase-type plasminogen activator promotes paracellular transmigration of neutrophils via Mac-1, but independently of urokinase-type plasminogen activator receptor. Circulation. 124: 1848-59. PMID 21969013 DOI: 10.1161/Circulationaha.110.017012 |
0.164 |
|
| 2020 |
Prell T, Siebecker F, Lorrain M, Tönges L, Warnecke T, Klucken J, Wellach I, Buhmann C, Wolz M, Lorenzl S, Herbst H, Eggers C, Mai T. Specialized Staff for the Care of People with Parkinson's Disease in Germany: An Overview. Journal of Clinical Medicine. 9. PMID 32784969 DOI: 10.3390/jcm9082581 |
0.16 |
|
| 2015 |
Sieb JP, Themann P, Warnecke T, Lauterbach T, Berkels R, Grieger F, Lorenzl S. Caregivers' and physicians' attitudes to rotigotine transdermal patch versus oral Parkinson's disease medication: an observational study. Current Medical Research and Opinion. 31: 967-74. PMID 25772231 DOI: 10.1185/03007995.2015.1030376 |
0.158 |
|
| 2023 |
Bublitz SK, Brandstötter C, Fegg M, Ferreira JJ, Odin P, Bloem BR, Meissner WG, Dodel R, Schrag A, Lorenzl S. Meaning in Life in Late-Stage Parkinson's Disease: Results from the Care of Late-Stage Parkinsonism Study (CLaSP) in Six European Countries. Journal of Religion and Health. PMID 38049708 DOI: 10.1007/s10943-023-01962-w |
0.158 |
|
| 2018 |
Balzer-Geldsetzer M, Ferreira J, Odin P, Bloem BR, Meissner WG, Lorenzl S, Wittenberg M, Dodel R, Schrag A. Study protocol: Care of Late-Stage Parkinsonism (CLaSP): a longitudinal cohort study. Bmc Neurology. 18: 185. PMID 30396331 DOI: 10.1186/s12883-018-1184-3 |
0.156 |
|
| 2018 |
Lex KM, Kundt FS, Lorenzl S. Using tube feeding and levodopa-carbidopa intestinal gel application in advanced Parkinson's disease. British Journal of Nursing (Mark Allen Publishing). 27: 259-262. PMID 29517331 DOI: 10.12968/bjon.2018.27.5.259 |
0.156 |
|
| 2009 |
Lorenzl S. [Parkinson's disease and atypical Parkinson syndromes]. Mmw Fortschritte Der Medizin. 151: 39-40. PMID 20088320 |
0.153 |
|
| 2022 |
Reichmann H, Csoti I, Koschel J, Lorenzl S, Schrader C, Winkler J, Wüllner U. Life style and Parkinson's disease. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 35606622 DOI: 10.1007/s00702-022-02509-1 |
0.151 |
|
| 2020 |
Prell T, Siebecker F, Lorrain M, Eggers C, Lorenzl S, Klucken J, Warnecke T, Buhmann C, Tönges L, Ehret R, Wellach I, Wolz M. Recommendations for Standards of Network Care for Patients with Parkinson's Disease in Germany. Journal of Clinical Medicine. 9. PMID 32414071 DOI: 10.3390/jcm9051455 |
0.15 |
|
| 2013 |
Mackenzie IR, Arzberger T, Kremmer E, Troost D, Lorenzl S, Mori K, Weng SM, Haass C, Kretzschmar HA, Edbauer D, Neumann M. Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations. Acta Neuropathologica. 126: 859-79. PMID 24096617 DOI: 10.1007/S00401-013-1181-Y |
0.149 |
|
| 2006 |
Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schäfer H, Bötzel K, Daniels C, Deutschländer A, Dillmann U, Eisner W, Gruber D, Hamel W, Herzog J, Hilker R, Klebe S, ... ... Lorenzl S, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. The New England Journal of Medicine. 355: 896-908. PMID 16943402 DOI: 10.1056/Nejmoa060281 |
0.146 |
|
| 2013 |
Zwergal A, la Fougère C, Lorenzl S, Rominger A, Xiong G, Deutschenbaur L, Schöberl F, Linn J, Dieterich M, Brandt T, Strupp M, Bartenstein P, Jahn K. Functional disturbance of the locomotor network in progressive supranuclear palsy. Neurology. 80: 634-41. PMID 23345641 DOI: 10.1212/WNL.0b013e318281cc43 |
0.144 |
|
| 2016 |
Levin J, Maaß S, Schuberth M, Respondek G, Paul F, Mansmann U, Oertel WH, Lorenzl S, Krismer F, Seppi K, Poewe W, Wenning G, Giese A, Bötzel K, et al. The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 26809243 DOI: 10.1007/s00702-016-1507-8 |
0.142 |
|
| 2018 |
Lex KM, Larkin P, Osterbrink J, Lorenzl S. A Pilgrim's Journey-When Parkinson's Disease Comes to an End in Nursing Homes. Frontiers in Neurology. 9: 1068. PMID 30619034 DOI: 10.3389/fneur.2018.01068 |
0.142 |
|
| 2018 |
Eva Weck C, Lorenzl S. [Neuropalliative care aspects in patients with Parkinson's disease]. Fortschritte Der Neurologie-Psychiatrie. 86: S30-S33. PMID 30241098 DOI: 10.1055/a-0671-2115 |
0.142 |
|
| 2006 |
Glas M, Popp B, Angele B, Ködel U, Pfister H, Lorenzl S. Urinary-type plasminogen activator and its receptor is elevated in G93A Mice Aktuelle Neurologie. 33. DOI: 10.1055/s-2006-952987 |
0.142 |
|
| 1995 |
Lorenzl S, Koedel U, Frei K, Bernatowicz A, Fontana A, Pfister HW. Protective effect of a 21-aminosteroid during experimental pneumococcal meningitis. The Journal of Infectious Diseases. 172: 113-8. PMID 7797900 |
0.139 |
|
| 2021 |
Nuebling GS, Butzhammer E, Lorenzl S. Assisted Suicide in Parkinsonian Disorders. Frontiers in Neurology. 12: 656599. PMID 33790854 DOI: 10.3389/fneur.2021.656599 |
0.138 |
|
| 2021 |
Rosqvist K, Odin P, Lorenzl S, Meissner WG, Bloem BR, Ferreira JJ, Dodel R, Schrag A. Factors Associated with Health-Related Quality of Life in Late-Stage Parkinson's Disease. Movement Disorders Clinical Practice. 8: 563-570. PMID 33981789 DOI: 10.1002/mdc3.13186 |
0.137 |
|
| 2019 |
Paal P, Lorenzl S. Patients with Parkinson's disease need spiritual care. Annals of Palliative Medicine. PMID 31865747 DOI: 10.21037/apm.2019.11.24 |
0.137 |
|
| 2018 |
Kammermeier S, Maierbeck K, Dietrich L, Plate A, Lorenzl S, Singh A, Bötzel K, Maurer C. Qualitative postural control differences in Idiopathic Parkinson's Disease vs. Progressive Supranuclear Palsy with dynamic-on-static platform tilt. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 129: 1137-1147. PMID 29631169 DOI: 10.1016/J.Clinph.2018.03.002 |
0.135 |
|
| 2021 |
Chaudhuri KR, Rukavina K, McConvey V, Antonini A, Lorenzl S, Bhidayasiri R, Piemonte MEP, Lim SY, Richfield E, Walker R, Bouca-Machado R, Bajwah S, Gao W, Trivedi D, Miyasaki J. The Impact of COVID-19 on Palliative Care for People with Parkinson's and Response to Future Pandemics. Expert Review of Neurotherapeutics. PMID 33905283 DOI: 10.1080/14737175.2021.1923480 |
0.135 |
|
| 1998 |
Koedel U, Lorenzl S, Gorriz C, Arendt RM, Pfister HW. Endothelin B receptor-mediated increase of cerebral blood flow in experimental pneumococcal meningitis. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 18: 67-74. PMID 9428307 DOI: 10.1097/00004647-199801000-00007 |
0.133 |
|
| 2021 |
Meinders MJ, Gentile G, Schrag AE, Konitsiotis S, Eggers C, Taba P, Lorenzl S, Odin P, Rosqvist K, Chaudhuri KR, Antonini A, Bloem BR, Groot MM. Advance Care Planning and Care Coordination for People With Parkinson's Disease and Their Family Caregivers-Study Protocol for a Multicentre, Randomized Controlled Trial. Frontiers in Neurology. 12: 673893. PMID 34434156 DOI: 10.3389/fneur.2021.673893 |
0.13 |
|
| 2023 |
Paal P, Avión Martínez S, Lorenzl S, Goldzweig G. A Rejoinder to Otaiku: Religiosity and Risk of Parkinson's Disease in England and the USA-The Health Determinants of Spirituality, Religiosity and the Need for State of the Art Research. Journal of Religion and Health. PMID 36607565 DOI: 10.1007/s10943-022-01726-y |
0.128 |
|
| 2008 |
Hinterberger K, Ostwald A, Löper ML, Levin J, Lorenzl S, Ziegler W. Progression and degree of severity of dysarthria in patients with progressive supranuclear palsy (PSP) and idiopathic Parkinsonism (IPS) | Verlauf und schweregrad der dysarthrie bei patienten mit progressiver supranukleärer blickparese (PSP) und idiopathischem Parkinson-syndrom (IPS) Neurologie Und Rehabilitation. 14: 247-253. |
0.128 |
|
| 2019 |
Ebersbach G, Ip CW, Klebe S, Koschel J, Lorenzl S, Schrader C, Winkler C, Franke C. Management of delirium in Parkinson's disease. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 30725186 DOI: 10.1007/s00702-019-01980-7 |
0.127 |
|
| 2017 |
Nübling G, Schuberth M, Feldmer K, Giese A, Holdt LM, Teupser D, Lorenzl S. Cathepsin S increases tau oligomer formation through limited cleavage, but only IL-6, not cathespin S serum levels correlate with disease severity in the neurodegenerative tauopathy progressive supranuclear palsy. Experimental Brain Research. 235: 2407-2412. PMID 28493068 DOI: 10.1007/s00221-017-4978-4 |
0.125 |
|
| 2008 |
Lorenzl S. Mmw Fortschritte Der Medizin. 150: 23. PMID 27369393 DOI: 10.1007/BF03365757 |
0.12 |
|
| 2014 |
Nübling GS, Mie E, Bauer RM, Hensler M, Lorenzl S, Hapfelmeier A, Irwin DE, Borasio GD, Winkler AS. Increased prevalence of bladder and intestinal dysfunction in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 15: 174-9. PMID 24479577 DOI: 10.3109/21678421.2013.868001 |
0.119 |
|
| 2020 |
Hommel ALAJ, Meinders MJ, Lorenzl S, Dodel R, Coelho M, Ferreira JJ, Laurens B, Spampinato U, Meissner W, Rosqvist K, Timpka J, Odin P, Wittenberg M, Bloem PhD BR, Koopmans RT, et al. The Prevalence and Determinants of Neuropsychiatric Symptoms in Late-Stage Parkinsonism. Movement Disorders Clinical Practice. 7: 531-542. PMID 32626798 DOI: 10.1002/mdc3.12968 |
0.119 |
|
| 2024 |
Pigott JS, Bloem BR, Lorenzl S, Meissner WG, Odin P, Ferreira JJ, Dodel R, Schrag A. The Care Needs of Patients With Cognitive Impairment in Late-Stage Parkinson's Disease. Journal of Geriatric Psychiatry and Neurology. 8919887231225484. PMID 38230692 DOI: 10.1177/08919887231225484 |
0.117 |
|
| 2010 |
Lorenzl S. Palliative care and Parkinson's disease | Palliative versorgung Nervenheilkunde. 29: 368-371. |
0.116 |
|
| 2013 |
Voltz R, Nübling G, Lorenzl S. Care of the dying neurologic patient. Handbook of Clinical Neurology. 118: 141-5. PMID 24182373 DOI: 10.1016/B978-0-444-53501-6.00011-1 |
0.115 |
|
| 2021 |
Bublitz SK, Weck C, Egger-Rainer A, Lex K, Paal P, Lorenzl S. Palliative Care Challenges of Patients With Progressive Bulbar Palsy: A Retrospective Case Series of 14 Patients. Frontiers in Neurology. 12: 700103. PMID 34630279 DOI: 10.3389/fneur.2021.700103 |
0.114 |
|
| 2009 |
Stanger O, Fowler B, Piertzik K, Huemer M, Haschke-Becher E, Semmler A, Lorenzl S, Linnebank M. Homocysteine, folate and vitamin B12 in neuropsychiatric diseases: review and treatment recommendations. Expert Review of Neurotherapeutics. 9: 1393-412. PMID 19769453 DOI: 10.1586/ern.09.75 |
0.108 |
|
| 2017 |
Dieplinger A, Kundt FS, Lorenzl S. Palliative care nursing for patients with neurological diseases: what makes the difference? British Journal of Nursing (Mark Allen Publishing). 26: 356-359. PMID 28345980 DOI: 10.12968/bjon.2017.26.6.356 |
0.103 |
|
| 2021 |
Kruse C, Kretschmer S, Lipinski A, Verheyen M, Mengel D, Balzer-Geldsetzer M, Lorenzl S, Richinger C, Schmotz C, Tönges L, Woitalla D, Klebe S, Schrag A, Dodel R. Resource Utilization of Patients with Parkinson's Disease in the Late Stages of the Disease in Germany: Data from the CLaSP Study. Pharmacoeconomics. PMID 33738776 DOI: 10.1007/s40273-021-01011-y |
0.101 |
|
| 2018 |
Galazky I, Kaufmann J, Lorenzl S, Ebersbach G, Gandor F, Zaehle T, Specht S, Stallforth S, Sobieray U, Wirkus E, Casjens F, Heinze HJ, Kupsch A, Voges J. Deep brain stimulation of the pedunculopontine nucleus for treatment of gait and balance disorder in progressive supranuclear palsy: Effects of frequency modulations and clinical outcome. Parkinsonism & Related Disorders. PMID 29503154 DOI: 10.1016/J.Parkreldis.2018.02.027 |
0.1 |
|
| 2014 |
Uenal H, Rosenbohm A, Kufeldt J, Weydt P, Goder K, Ludolph A, Rothenbacher D, Nagel G, Adam T, Arnold G, Baier H, Bäzner H, Beattie J, Behne F, Bengel D, ... ... Lorenzl S, et al. Incidence and geographical variation of Amyotrophic Lateral Sclerosis (als) in Southern Germany - Completeness of the ALS registry Swabia Plos One. 9. PMID 24722455 DOI: 10.1371/journal.pone.0093932 |
0.099 |
|
| 2007 |
Mallien G, Hinterberger K, Ostwald A, Löper M, Lorenzl S, Ziegler W. 1.213 Dysarthria in progressive supranuclear palsy Parkinsonism & Related Disorders. 13: S63-S64. DOI: 10.1016/S1353-8020(08)70486-3 |
0.098 |
|
| 2023 |
Garon M, Weck C, Rosqvist K, Odin P, Schrag A, Krikmann Ü, Pedrosa DJ, Antonini A, Lorenzl S, Martins Pereira S, Paal P. A systematic practice review: Providing palliative care for people with Parkinson's disease and their caregivers. Palliative Medicine. 2692163231214408. PMID 38054428 DOI: 10.1177/02692163231214408 |
0.097 |
|
| 1996 |
Lorenzl S, Ködel U, Frei K, Pfister HW. Effect of the bradykinin B2 receptor antagonist Hoe140 in experimental pneumococcal meningitis in the rat. European Journal of Pharmacology. 308: 335-41. PMID 8858309 DOI: 10.1016/0014-2999(96)00375-5 |
0.096 |
|
| 2017 |
Respondek G, Kurz C, Arzberger T, Compta Y, Englund E, Ferguson LW, Gelpi E, Giese A, Irwin DJ, Meissner WG, Nilsson C, Pantelyat A, Rajput A, van Swieten JC, Troakes C, ... ... Lorenzl S, et al. Which ante mortem clinical features predict progressive supranuclear palsy pathology? Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28500752 DOI: 10.1002/Mds.27034 |
0.094 |
|
| 2016 |
Nuebling G, Hensler M, Paul S, Zwergal A, Crispin A, Lorenzl S. PROSPERA: a randomized, controlled trial evaluating rasagiline in progressive supranuclear palsy. Journal of Neurology. PMID 27230855 DOI: 10.1007/s00415-016-8169-1 |
0.094 |
|
| 2017 |
Kammermeier S, Dietrich L, Maierbeck K, Plate A, Lorenzl S, Singh A, Bötzel K. Neck Vibration Proprioceptive Postural Response Intact in Progressive Supranuclear Palsy unlike Idiopathic Parkinson's Disease. Frontiers in Neurology. 8: 689. PMID 29326649 DOI: 10.3389/Fneur.2017.00689 |
0.093 |
|
| 2011 |
Hensler M, Paul S, Abright C, Lorenzl S. [Progressive supranuclear palsy: living environment of the patients in Germany]. Der Nervenarzt. 82: 207-14. PMID 20669002 DOI: 10.1007/s00115-010-3076-7 |
0.093 |
|
| 2020 |
Kalampokini S, Hommel ALAJ, Lorenzl S, Ferreira JJ, Meissner WG, Odin P, Bloem BR, Dodel R, Schrag AE. Caregiver Burden in Late-Stage Parkinsonism and Its Associations. Journal of Geriatric Psychiatry and Neurology. 891988720968263. PMID 33094677 DOI: 10.1177/0891988720968263 |
0.093 |
|
| 2017 |
Schmotz C, Richinger C, Lorenzl S. High Burden and Depression Among Late-Stage Idiopathic Parkinson Disease and Progressive Supranuclear Palsy Caregivers. Journal of Geriatric Psychiatry and Neurology. 891988717720300. PMID 28747135 DOI: 10.1177/0891988717720300 |
0.09 |
|
| 1992 |
Pfister HW, Koedel U, Lorenzl S, Tomasz A. Antioxidants attenuate microvascular changes in the early phase of experimental pneumococcal meningitis in rats. Stroke; a Journal of Cerebral Circulation. 23: 1798-804. PMID 1448831 |
0.087 |
|
| 2009 |
Zwergal A, La Fougere C, Bartenstein P, Lorenzl S, Strupp M, Brandt T, Dieterich M, Jahn K. Brain activation patterns during real locomotion in progressive supranuclear palsy Aktuelle Neurologie. 36. DOI: 10.1055/s-0029-1238366 |
0.086 |
|
| 2007 |
Levin J, Lorenzl S, Habeck M, Bötzel K, Kretzschmar H, Giese A. Effect of protease cleavage on de novo aggregation of alpha-synuclein Aktuelle Neurologie. 34. DOI: 10.1055/s-2007-987894 |
0.086 |
|
| 2020 |
Nuebling GS, Plesch E, Ruf VC, Högen T, Lorenzl S, Kamp F, Giese A, Levin J. Binding of metal ion induced tau oligomers to lipid surfaces is enhanced by GSK-3β mediated phosphorylation. Acs Chemical Neuroscience. PMID 32069020 DOI: 10.1021/acschemneuro.9b00459 |
0.084 |
|
| 2021 |
Gatsios D, Antonini A, Gentile G, Konitsiotis S, Fotiadis D, Nixina I, Taba P, Weck C, Lorenzl S, Lex KM, Paal P. Education on palliative care for Parkinson patients: development of the "Best care for people with late-stage Parkinson's disease" curriculum toolkit. Bmc Medical Education. 21: 538. PMID 34696752 DOI: 10.1186/s12909-021-02964-6 |
0.083 |
|
| 2022 |
Bublitz SK, Mie E, Wasner M, Hapfelmeier A, Geiseler J, Lorenzl S, Winkler AS. Thick Mucus in ALS: A Mixed-Method Study on Associated Factors and Its Impact on Quality of Life of Patients and Caregivers. Brain Sciences. 12. PMID 35204016 DOI: 10.3390/brainsci12020252 |
0.083 |
|
| 2014 |
Lorenzl S. [Multimorbidity of neurological patients in palliative care units]. Der Nervenarzt. 85: 409-16. PMID 24682167 DOI: 10.1007/s00115-013-3938-x |
0.081 |
|
| 2014 |
Boxer AL, Lang AE, Grossman M, Knopman DS, Miller BL, Schneider LS, Doody RS, Lees A, Golbe LI, Williams DR, Corvol JC, Ludolph A, Burn D, Lorenzl S, Litvan I, et al. Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial. The Lancet. Neurology. 13: 676-85. PMID 24873720 DOI: 10.1016/S1474-4422(14)70088-2 |
0.079 |
|
| 2022 |
Oliver D, Baker I, Borasio GD, Cras P, Faull C, Hepgul N, Lorenzl S, Stockdale C, de Visser M, Vanopdenbosch L, Voltz R, Veronese S. The involvement of palliative care with neurology - a comparison of UK, Switzerland and Italy. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-7. PMID 36288469 DOI: 10.1080/21678421.2022.2136993 |
0.076 |
|
| 2018 |
Spielberger A, Lorenzl S. [Laryngospasm in amyotrophic lateral sclerosis : A case report]. Wiener Medizinische Wochenschrift (1946). PMID 29450783 DOI: 10.1007/s10354-018-0620-8 |
0.076 |
|
| 2018 |
Burger S, Lorenzl S. [Paraneoplastic cerebellar degeneration (PCD) - an interdisciplinary challenge in neurology, oncology and palliative care]. Wiener Medizinische Wochenschrift (1946). PMID 29411193 DOI: 10.1007/s10354-018-0624-4 |
0.075 |
|
| 2014 |
Nübling GS, Levin J, Bader B, Lorenzl S, Hillmer A, Högen T, Kamp F, Giese A. Modelling Ser129 phosphorylation inhibits membrane binding of pore-forming alpha-synuclein oligomers. Plos One. 9: e98906. PMID 24911099 DOI: 10.1371/journal.pone.0098906 |
0.074 |
|
| 2013 |
Lorenzl S, Nübling G, Perrar KM, Voltz R. Palliative treatment of chronic neurologic disorders. Handbook of Clinical Neurology. 118: 133-9. PMID 24182372 DOI: 10.1016/B978-0-444-53501-6.00010-X |
0.073 |
|
| 1996 |
Lorenzl S, Koedel U, Pfister HW. Mannitol, but not allopurinol, modulates changes in cerebral blood flow, intracranial pressure, and brain water content during pneumococcal meningitis in the rat. Critical Care Medicine. 24: 1874-80. PMID 8917039 DOI: 10.1097/00003246-199611000-00018 |
0.073 |
|
| 2020 |
Hommel ALAJ, Meinders MJ, Weerkamp NJ, Richinger C, Schmotz C, Lorenzl S, Dodel R, Coelho M, Ferreira JJ, Tison F, Boraud T, Meissner WG, Rosqvist K, Timpka J, Odin P, et al. Optimizing Treatment in Undertreated Late-Stage Parkinsonism: A Pragmatic Randomized Trial. Journal of Parkinson's Disease. PMID 32568111 DOI: 10.3233/Jpd-202033 |
0.073 |
|
| 2015 |
Oliver DJ, Borasio GD, Caraceni A, de Visser M, Grisold W, Lorenzl S, Veronese S, Voltz R. A consensus review on the development of palliative care for patients with chronic and progressive neurological disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. PMID 26423203 DOI: 10.1111/ene.12889 |
0.072 |
|
| 2017 |
Hendriksz CJ, Anheim M, Bauer P, Bonnot O, Chakrapani A, Corvol JC, de Koning TJ, Degtyareva A, Dionisi-Vici C, Doss S, Duning T, Giunti P, Iodice R, Johnston T, Kelly D, ... ... Lorenzl S, et al. The hidden Niemann-Pick type C patient: clinical niches for a rare inherited metabolic disease. Current Medical Research and Opinion. 1-14. PMID 28276873 DOI: 10.1080/03007995.2017.1294054 |
0.068 |
|
| 1996 |
Lorenzl S, Pfister HW, Padovan C, Yousry T. MRI abnormalities in tick-borne encephalitis. Lancet. 347: 698-9. PMID 8596421 |
0.067 |
|
| 2017 |
Kammermeier S, Dietrich L, Maierbeck K, Plate A, Lorenzl S, Singh A, Ahmadi A, Bötzel K. Postural Stabilization Differences in Idiopathic Parkinson's Disease and Progressive Supranuclear Palsy during Self-Triggered Fast Forward Weight Lifting. Frontiers in Neurology. 8: 743. PMID 29403423 DOI: 10.3389/Fneur.2017.00743 |
0.067 |
|
| 2020 |
Hosking A, Hommel AALJ, Lorenzl S, Coelho M, Ferreira JJ, Meissner WG, Odin P, Bloem BR, Dodel R, Schrag A. Characteristics of Patients with Late-Stage Parkinsonism who are Nursing Home Residents Compared with those Living at Home. Journal of the American Medical Directors Association. PMID 32723531 DOI: 10.1016/j.jamda.2020.06.025 |
0.067 |
|
| 2009 |
Schneider M, Hoffmann M, Lorenzl S. Evaluating the use of the Cleo 90 infusion set for patients on a palliative care unit. International Journal of Palliative Nursing. 15: 372-6. PMID 19773700 DOI: 10.12968/ijpn.2009.15.8.43795 |
0.066 |
|
| 2012 |
Lorenzl S, Füsgen I, Noachtar S. Acute confusional States in the elderly--diagnosis and treatment. Deutsches ã„Rzteblatt International. 109: 391-9; quiz 400. PMID 22690255 DOI: 10.3238/arztebl.2012.0391 |
0.065 |
|
| 2014 |
Rémi C, Lorenzl S, Vyhnalek B, Rastorfer K, Feddersen B. Continuous subcutaneous use of levetiracetam: a retrospective review of tolerability and clinical effects. Journal of Pain & Palliative Care Pharmacotherapy. 28: 371-7. PMID 25313924 DOI: 10.3109/15360288.2014.959234 |
0.063 |
|
| 2010 |
Lorenzl S, Mayer S, Feddersen B, Jox R, Noachtar S, Borasio GD. Nonconvulsive status epilepticus in palliative care patients. Journal of Pain and Symptom Management. 40: 460-5. PMID 20594804 DOI: 10.1016/j.jpainsymman.2010.01.019 |
0.062 |
|
| 2022 |
Gursahani R, Lorenzl S. International models of neuropalliative care. Handbook of Clinical Neurology. 190: 73-84. PMID 36055721 DOI: 10.1016/B978-0-323-85029-2.00012-9 |
0.061 |
|
| 2022 |
Gatter S, Brukamp K, Adolf D, Zerth J, Lorenzl S, Weck C. Neurological consultations via telemedicine for specialized outpatient palliative care (SOPC) at home and in hospice (TANNE project): study protocol for a randomized controlled trial. Bmc Palliative Care. 21: 218. PMID 36471382 DOI: 10.1186/s12904-022-01088-y |
0.059 |
|
| 2011 |
Lorenzl S, Hensler M, Abright C, Deutschenbaur L, Paul S, Pfannschmidt C, Baumgartner A. P106 PROSPERA (PROgressive Supranuclear Palsy and the Effect of Rasagiline) Basal Ganglia. 1: 21. DOI: 10.1016/j.baga.2011.01.026 |
0.058 |
|
| 2015 |
Levin J, Bak TH, Rominger A, Mille E, Arzberger T, Giese A, Ackl N, Lorenzl S, Bader B, Patzig M, Bötzel K, Danek A. The association of aphasia and right-sided motor impairment in corticobasal syndrome. Journal of Neurology. 262: 2241-6. PMID 26143172 DOI: 10.1007/s00415-015-7833-1 |
0.057 |
|
| 1997 |
Koedel U, Gorriz C, Lorenzl S, Pfister HW. Increased endothelin levels in cerebrospinal fluid samples from adults with bacterial meningitis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 25: 329-30. PMID 9332538 |
0.055 |
|
| 2021 |
Haber G, Loffeld M, Braumiller M, Lorenzl S. Left hemispheric cortical watershed infarcts triggered by carotid sinus self-massage. Bmj Case Reports. 14. PMID 34920996 DOI: 10.1136/bcr-2021-244926 |
0.055 |
|
| 2007 |
Herrmann W, Lorenzl S, Obeid R. [Review of the role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric disorders--current evidence and preliminary recommendations]. Fortschritte Der Neurologie-Psychiatrie. 75: 515-27. PMID 17729191 DOI: 10.1055/s-2007-980112 |
0.055 |
|
| 1993 |
Lorenzl S, Koedel U, Dirnagl U, Ruckdeschel G, Pfister HW. Imaging of leukocyte-endothelium interaction using in vivo confocal laser scanning microscopy during the early phase of experimental pneumococcal meningitis. The Journal of Infectious Diseases. 168: 927-33. PMID 7690826 DOI: 10.1093/Infdis/168.4.927 |
0.054 |
|
| 2018 |
Dodel R, Koschel J, Lorenzl S, Levin J, van Eimeren T, Höglinger G. [Dementia with Lewy bodies]. Fortschritte Der Neurologie-Psychiatrie. 86: S43-S47. PMID 30241100 DOI: 10.1055/a-0696-6249 |
0.053 |
|
| 1997 |
Pfister HW, Lorenzl S, Yousry T. Neuroradiographic manifestations of encephalitis. The New England Journal of Medicine. 337: 1393-4. PMID 9380097 DOI: 10.1056/NEJM199711063371916 |
0.053 |
|
| 2020 |
Paal P, Lex KM, Brandstötter C, Weck C, Lorenzl S. Spiritual care as an integrated approach to palliative care for patients with neurodegenerative diseases and their caregivers: a literature review. Annals of Palliative Medicine. PMID 32279521 DOI: 10.21037/apm.2020.03.37 |
0.052 |
|
| 2018 |
Egger-Rainer A, Lorenzl S, Trinka E. Assessing comfort in the epilepsy monitoring unit: Development of an instrument. Epilepsy & Behavior : E&B. PMID 29793841 DOI: 10.1016/j.yebeh.2018.05.004 |
0.051 |
|
| 1996 |
Lorenzl S, Pfister HW, Padovan C, Yousry T. MRI abnormalities in tickborne encephalitis [22] Lancet. 347: 698-699. DOI: 10.1016/S0140-6736(96)91256-8 |
0.05 |
|
| 2021 |
Egger-Rainer A, Hettegger SM, Feldner R, Arnold S, Bosselmann C, Hamer H, Hengsberger A, Lang J, Lorenzl S, Lerche H, Noachtar S, Pataraia E, Schulze-Bonhage A, Staack AM, Trinka E, et al. Do all patients in the epilepsy monitoring unit experience the same level of comfort? A quantitative exploratory secondary analysis. Journal of Advanced Nursing. PMID 34837405 DOI: 10.1111/jan.15105 |
0.049 |
|
| 2019 |
Weck CE, Lex KM, Lorenzl S. Telemedicine in Palliative Care: Implementation of New Technologies to Overcome Structural Challenges in the Care of Neurological Patients. Frontiers in Neurology. 10: 510. PMID 31178815 DOI: 10.3389/fneur.2019.00510 |
0.049 |
|
| 2014 |
Bükki J, Nübling G, Lorenzl S. Managing Advanced Progressive Supranuclear Palsy and Corticobasal Degeneration in a Palliative Care Unit: Admission Triggers and Outcomes. The American Journal of Hospice & Palliative Care. PMID 25550443 DOI: 10.1177/1049909114565110 |
0.049 |
|
| 2011 |
Zwergal A, la Fougère C, Lorenzl S, Rominger A, Xiong G, Deutschenbaur L, Linn J, Krafczyk S, Dieterich M, Brandt T, Strupp M, Bartenstein P, Jahn K. Postural imbalance and falls in PSP correlate with functional pathology of the thalamus. Neurology. 77: 101-9. PMID 21613601 DOI: 10.1212/WNL.0b013e318223c79d |
0.047 |
|
| 2014 |
Fegg MJ, Kögler M, Abright C, Hensler M, Lorenzl S. Meaning in life in patients with progressive supranuclear palsy. The American Journal of Hospice & Palliative Care. 31: 543-7. PMID 23785042 DOI: 10.1177/1049909113492411 |
0.044 |
|
| 2021 |
Vaismoradi M, Behboudi-Gandevani S, Lorenzl S, Weck C, Paal P. Needs Assessment of Safe Medicines Management for Older People With Cognitive Disorders in Home Care: An Integrative Systematic Review. Frontiers in Neurology. 12: 694572. PMID 34539551 DOI: 10.3389/fneur.2021.694572 |
0.042 |
|
| 2019 |
Baumann L, Klösch M, Greger M, Dieplinger A, Lorenzl S. [Amyotrophic Lateral Sclerosis - Challenges of Family Caregivers]. Fortschritte Der Neurologie-Psychiatrie. PMID 31261412 DOI: 10.1055/a-0934-6163 |
0.042 |
|
| 2023 |
Ziegler W, Schölderle T, Brendel B, Risch V, Felber S, Ott K, Goldenberg G, Vogel M, Bötzel K, Zettl L, Lorenzl S, Lampe R, Strecker K, Synofzik M, Lindig T, et al. Speech and Nonspeech Parameters in the Clinical Assessment of Dysarthria: A Dimensional Analysis. Brain Sciences. 13. PMID 36672094 DOI: 10.3390/brainsci13010113 |
0.042 |
|
| 2021 |
Vaismoradi M, Jamshed S, Lorenzl S, Paal P. PRN Medicines Management for Older People with Long-Term Mental Health Disorders in Home Care. Risk Management and Healthcare Policy. 14: 2841-2849. PMID 34262371 DOI: 10.2147/RMHP.S316744 |
0.039 |
|
| 2017 |
Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, ... ... Lorenzl S, et al. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28467028 DOI: 10.1002/Mds.26987 |
0.039 |
|
| 2013 |
Lorenzl S. End of one's life-Decision making between autonomy and uncertainty Geriatric Mental Health Care. 1: 63-66. DOI: 10.1016/j.gmhc.2013.04.009 |
0.039 |
|
| 2008 |
Lorenzl S, Mayer S, Noachtar S, Borasio GD. Nonconvulsive status epilepticus in terminally ill patients-a diagnostic and therapeutic challenge. Journal of Pain and Symptom Management. 36: 200-5. PMID 18395399 DOI: 10.1016/j.jpainsymman.2007.10.006 |
0.038 |
|
| 2021 |
Riesinger R, Altmann K, Lorenzl S. Involvement of Specialist Palliative Care in a Stroke Unit in Austria-Challenges for Families and Stroke Teams. Frontiers in Neurology. 12: 683624. PMID 34630274 DOI: 10.3389/fneur.2021.683624 |
0.037 |
|
| 2007 |
Vogeser M, Lorenzl S. Comparison of automated assays for the determination of vitamin B12 in serum. Clinical Biochemistry. 40: 1342-5. PMID 17889846 DOI: 10.1016/j.clinbiochem.2007.08.004 |
0.03 |
|
| 2022 |
Paal P, Brandstötter C, Elsner F, Lorenzl S, Osterbrink J, Stähli A. European interprofessional postgraduate curriculum in palliative care: A narrative synthesis of field interviews in the region of Middle, Eastern, and Southeastern Europe and Central and West Asia. Palliative & Supportive Care. 1-10. PMID 36545761 DOI: 10.1017/S1478951522001651 |
0.03 |
|
| 2013 |
Lorenzl S. Infusion pumps in palliative care are vital, but many need updating. British Journal of Nursing (Mark Allen Publishing). 22: S4. PMID 24067272 DOI: 10.12968/bjon.2013.22.Sup17.S4 |
0.027 |
|
| 2006 |
Vogeser M, Müller W, Lorenzl S. External quality control of urinary methyl malonic acid quantification - announcement of a pilot study. Clinical Chemistry and Laboratory Medicine : Cclm / Fescc. 44: 123-4. PMID 16375598 DOI: 10.1515/CCLM.2006.023 |
0.027 |
|
| 2019 |
Goldschagg N, Bremova-Ertl T, Bardins S, Dinca N, Feil K, Krafczyk S, Lorenzl S, Strupp M. No Evidence of a Contribution of the Vestibular System to Frequent Falls in Progressive Supranuclear Palsy. Journal of Clinical Neurology (Seoul, Korea). 15: 339-346. PMID 31286706 DOI: 10.3988/jcn.2019.15.3.339 |
0.027 |
|
| 2019 |
Egger-Rainer A, Lorenzl S, Trinka E. Considerations in preparing a multicenter study: Lessons learned from the Epilepsy Monitoring Unit Comfort Questionnaire (EMUCQ) validation feasibility study. Epilepsy & Behavior : E&B. 98: 53-58. PMID 31299533 DOI: 10.1016/j.yebeh.2019.06.019 |
0.027 |
|
| 2010 |
Lorenzl S, Singer M. Acupuncture in hemiplegic stroke patients - preliminary results Focus On Alternative and Complementary Therapies. 3: 189-190. DOI: 10.1111/j.2042-7166.1998.tb00939.x |
0.026 |
|
| 2023 |
Pitzer S, Kutschar P, Paal P, Mülleder P, Lorenzl S, Wosko P, Osterbrink J, Bükki J. Barriers for Adult Patients to Access Palliative Care in Hospitals: A Mixed Methods Systematic Review. Journal of Pain and Symptom Management. PMID 37717708 DOI: 10.1016/j.jpainsymman.2023.09.012 |
0.026 |
|
| 2020 |
Oliver D, Borasio GD, Veronese S, Voltz R, Lorenzl S, Hepgul N. Current collaboration between palliative care and neurology: a survey of clinicians in Europe. Bmj Supportive & Palliative Care. PMID 32651190 DOI: 10.1136/bmjspcare-2020-002322 |
0.026 |
|
| 2014 |
Bükki J, Unterpaul T, Nübling G, Jox RJ, Lorenzl S. Decision making at the end of life--cancer patients' and their caregivers' views on artificial nutrition and hydration. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 22: 3287-99. PMID 25084741 DOI: 10.1007/s00520-014-2337-6 |
0.025 |
|
| 2022 |
Lorenzl S, Gottwald F, Nistler A, Brehm L, Grötsch R, Haber G, Bremm C, Weck C, Trummer C, Brand W. A Phase I Trial to Determine the Pharmacokinetics, Psychotropic Effects, and Safety Profile of a Novel Nanoparticle-Based Cannabinoid Spray for Oromucosal Delivery. Medical Cannabis and Cannabinoids. 5: 9-19. PMID 35224436 DOI: 10.1159/000521352 |
0.025 |
|
| 2008 |
Lorenzl S, Linnebank M, Stanger O. B vitamins and cerebral ischemia. Deutsches äRzteblatt International. 105: 128-9; author reply . PMID 19633766 DOI: 10.3238/arztebl.2008.0128c |
0.024 |
|
| 2006 |
Peters N, Lorenzl S, Fischereder J, Bötzel K, Straube A. Hypnic headache: a case presentation including polysomnography. Cephalalgia : An International Journal of Headache. 26: 84-6. PMID 16396671 DOI: 10.1111/j.1468-2982.2006.01011.x |
0.023 |
|
| 2018 |
Brittain C, McCarthy A, Irizarry MC, McDermott D, Biglan K, Höglinger GU, Lorenzl S, Del Ser T, Boxer AL. Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations. Parkinsonism & Related Disorders. PMID 30201421 DOI: 10.1016/J.Parkreldis.2018.08.025 |
0.022 |
|
| 2009 |
Lorenzl S. [Spiritual care for gravely ill patients]. Mmw Fortschritte Der Medizin. 151: 41-2. PMID 20088321 |
0.022 |
|
| 2022 |
Liesche-Starnecker F, Schifferer M, Schlegel J, Vollmuth Y, Rubbenstroth D, Delbridge C, Gempt J, Lorenzl S, Schnurbus L, Misgeld T, Rosati M, Beer M, Matiasek K, Wunderlich S, Finck T. Hemorrhagic lesion with detection of infected endothelial cells in human bornavirus encephalitis. Acta Neuropathologica. PMID 35657496 DOI: 10.1007/s00401-022-02442-3 |
0.022 |
|
| 2006 |
Olzowy B, Lorenzl S, Guerkov R. Bilateral and unilateral internal carotid artery dissection causing isolated hypoglossal nerve palsy: a case report and review of the literature. European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (Eufos) : Affiliated With the German Society For Oto-Rhino-Laryngology - Head and Neck Surgery. 263: 390-3. PMID 16252123 DOI: 10.1007/s00405-005-1005-3 |
0.022 |
|
| 2019 |
Paal P, Brandstötter C, Lorenzl S, Larkin P, Elsner F. Postgraduate palliative care education for all healthcare providers in Europe: Results from an EAPC survey. Palliative & Supportive Care. 1-12. PMID 30683163 DOI: 10.1017/S1478951518000986 |
0.022 |
|
| 2021 |
Miyasaki JM, Lim SY, Chaudhuri KR, Antonini A, Piemonte M, Richfield E, Alburquerque Gonzalez D, Lorenzl S, Walker R, Bhidayasiri R, Bouca R, McConvey V. Access and Attitudes Toward Palliative Care Among Movement Disorders Clinicians. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 34431560 DOI: 10.1002/mds.28773 |
0.021 |
|
| 2012 |
Nübling G, Allmendinger S, Lorenzl S. [Drug therapy of anxiety and fear in palliative care patients with cancer or other illnesses : a systematic review]. Schmerz (Berlin, Germany). 26: 537-49. PMID 22968367 DOI: 10.1007/s00482-012-1241-6 |
0.02 |
|
| 2008 |
Egidi G, Gerken M, Lorenzl S, Linnebank M, Stanger O, Diener HC. Secondary stroke prevention: Recent advances | Sekundärprävention des schlaganfalls: Was ist neu? Deutsches Arzteblatt. 105: 128-129. DOI: 10.3238/arztebl.2008.0128a |
0.02 |
|
| 2017 |
Kramer S, Irnich D, Lorenzl S. Acupuncture for Symptom Relief in Palliative Care-Study Protocol and Semistandardized Treatment Schemes. Journal of Acupuncture and Meridian Studies. 10: 294-302. PMID 28889847 DOI: 10.1016/j.jams.2017.04.004 |
0.019 |
|
| 2014 |
Huemer M, Bürer C, Ješina P, Kožich V, Landolt MA, Suormala T, Fowler B, Augoustides-Savvopoulou P, Blair E, Brennerova K, Broomfield A, De Meirleir L, Gökcay G, Hennermann J, Jardine P, ... ... Lorenzl S, et al. Clinical onset and course, response to treatment and outcome in 24 patients with the cblE or cblG remethylation defect complemented by genetic and in vitro enzyme study data. Journal of Inherited Metabolic Disease. PMID 25526710 DOI: 10.1007/s10545-014-9803-7 |
0.018 |
|
| 2014 |
Lorenzl S. Intracranial pressure and epileptic seizures | Hirndruck und epileptische Anfälle Onkologe. 20: 261-266. DOI: 10.1007/s00761-013-2578-x |
0.017 |
|
| 2010 |
Borasio GD, Bausewein C, Lorenzl S, Voltz R, Wasner M. Palliative care in neuro-oncology Oncology of Cns Tumors. 783-788. DOI: 10.1007/978-3-642-02874-8_60 |
0.016 |
|
| 2008 |
Lorenzl S. [Vitamin B substitution. No protection for the heart -- but for the brain!]. Mmw Fortschritte Der Medizin. 150: 23. PMID 19149308 |
0.016 |
|
| 2003 |
Lorenzl S, Vogeser M, Müller-Schunk S, Pfister HW. Clinically and MRI documented funicular myelosis in a patient with metabolical vitamin B12 deficiency but normal vitamin B12 serum level. Journal of Neurology. 250: 1010-1. PMID 12928928 DOI: 10.1007/s00415-003-1161-6 |
0.016 |
|
| 2012 |
Hensler M, Remi J, Nübling GS, Lorenzl S. Prospective evaluation of the frequency and treatment of restless legs syndrome in a palliative care unit. Journal of Pain and Symptom Management. 44: e3-5. PMID 23131706 DOI: 10.1016/j.jpainsymman.2012.07.016 |
0.015 |
|
| 2007 |
Vogeser M, Müller W, Lorenzl S. External quality assessment of urinary methylmalonic acid quantification - results of a pilot study. Clinical Chemistry and Laboratory Medicine : Cclm / Fescc. 45: 695-6. PMID 17484638 DOI: 10.1515/CCLM.2007.109 |
0.015 |
|
| 2010 |
Kirchhoff F, Lorenzl S, Vogeser M. An on-line solid phase extraction procedure for the routine quantification of urinary methylmalonic acid by liquid chromatography-tandem mass spectrometry. Clinical Chemistry and Laboratory Medicine : Cclm / Fescc. 48: 1647-50. PMID 20704536 DOI: 10.1515/CCLM.2010.310 |
0.012 |
|
| 2020 |
Egger-Rainer A, Trinka E, Zimmermann G, Arnold S, Boßelmann C, Hamer H, Hengsberger A, Lang J, Lerche H, Noachtar S, Pataraia E, Schulze-Bonhage A, Staack AM, Unterberger I, Lorenzl S. Assessing comfort in the epilepsy monitoring unit: Psychometric testing of an instrument. Epilepsy & Behavior : E&B. 112: 107460. PMID 33181885 DOI: 10.1016/j.yebeh.2020.107460 |
0.011 |
|
| 2020 |
Egger-Rainer A, Trinka E, Zimmermann G, Arnold S, Boßelmann C, Hamer H, Hengsberger A, Lang J, Lerche H, Noachtar S, Pataraia E, Schulze-Bonhage A, Staack AM, Unterberger I, Lorenzl S. Assessing comfort in the epilepsy monitoring unit: Psychometric testing of an instrument Epilepsy & Behavior. 112: 107460. DOI: 10.1016/j.yebeh.2020.107460 |
0.011 |
|
| 2016 |
Ueberall MA, Lorenzl S, Lux EA, Voltz R, Perelman M. Efficacy, safety, and tolerability of fentanyl pectin nasal spray in patients with breakthrough cancer pain. Journal of Pain Research. 9: 571-85. PMID 27574463 DOI: 10.2147/JPR.S106177 |
0.01 |
|
| 2016 |
Levin J, Maaß S, Schuberth M, Respondek G, Paul F, Mansmann U, Oertel WH, Lorenzl S, Krismer F, Seppi K, Poewe W, Wenning G, Berg D, Claßen J, Ebersbach G, et al. Erratum to: The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 27562771 DOI: 10.1007/s00702-016-1602-x |
0.01 |
|
| 2014 |
Lorenzl S. Tips for the practical use in practice: Opiates for pain and breathlessness | Tipps für den praktischen umgang in der Praxis: Opiate gegen schmerzen und luftnot Cme. 12: 22-23. |
0.01 |
|
| 2013 |
Lorenzl S, Dieterich M. [Support to pass away]. Fortschritte Der Neurologie-Psychiatrie. 81: 677-8. PMID 24307085 DOI: 10.1055/s-0033-1356119 |
0.01 |
|
| 2013 |
Lorenzl S. In reply: Echocardiography is not a basic diagnostic test. Deutsches ã„Rzteblatt International. 110: 9. PMID 23450988 DOI: 10.3238/arztebl.2013.0009 |
0.01 |
|
| 2013 |
Nübling G, Schmidt F, Kamp F, Högen T, Johannes L, Lorenzl S, Giese A. Single particle investigation of membrane binding properties and Ca2+ conductivity of Fe3+-induced α-synuclein oligomers Basal Ganglia. 3: 39. DOI: 10.1016/j.baga.2013.01.003 |
0.01 |
|
| 2010 |
Schmich J, Porsche J, Vogel M, Kuny R, Mannsberger U, Lorenzl S, Levin J, Ziegler W. Everyday communication in dysarthria: A self-report questionnaire | Alltags- und kommunikationsbezogene Dysarthriediagnostik: Ein Fragebogen zur Selbsteinschätzung Sprache Stimme Gehor. 34: 73-79. DOI: 10.1055/s-0030-1253383 |
0.01 |
|
| Hide low-probability matches. |